Detection of germline and somatic pathogenic variants in patients with de novo metastatic breast cancer (dnMBC) and assessment of their prognostic relevance: A Hellenic Cooperative Oncology Group (HeCOG) translational cohort study

2026·

E. Fountzilas

,

K. Papadopoulou

Nikolaos Korfiatis

,

A. Goussia

,

A. Christopoulou

,

E. Moirogiorgou

,

N. Tsoukalas

,

G. Petrakis

,

C. Gouedard

,

F. Zagouri

,

D. Stefanou

,

F. Kyriakou

,

E. Vorrias

,

S. Karageorgopoulou

,

F. Dimitrakopoulos

,

A. Vernadou

,

S. Murray

,

G. Fountzilas

NCT05758948 Cite DOI

Journal Article Clinical Trial

Authors

Nikolaos Korfiatis

Professor of Data Management and Analytics

Professor of Data Management and Analytics at the Department of Informatics, Ionian University, Corfu. Senior Statistician of the Hellenic Cooperative Oncology Group (HeCOG).

---

← Comprehensive Molecular Profiling of Advanced NSCLC in Greek Patients: A Prospective HeCOG Study 2026

G3 Corfu Butterflies: A Small-Scale Benchmark for Long-Tailed Multi-Label Attribute Recognition 2026 →